Financial results - NOVOCLINIQUE SRL

Financial Summary - Novoclinique Srl
Unique identification code: 37831190
Registration number: J32/970/2017
Nace: 8690
Sales - Ron
102.893
Net Profit - Ron
186
Employees
1
Open Account
Company Novoclinique Srl with Fiscal Code 37831190 recorded a turnover of 2024 of 102.893, with a net profit of 186 and having an average number of employees of 1. The company operates in the field of Alte activitati referitoare la sanatatea umana having the NACE code 8690.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Novoclinique Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 0 0 4.944 47.907 102.943 86.139 87.192 102.893
Total Income - EUR - - 0 10.219 6.612 50.341 105.323 88.328 89.573 105.284
Total Expenses - EUR - - 0 15.957 22.104 47.379 85.377 81.884 84.533 105.064
Gross Profit/Loss - EUR - - 0 -5.739 -15.492 2.962 19.946 6.445 5.039 220
Net Profit/Loss - EUR - - 0 -5.739 -15.540 2.501 18.938 5.713 4.298 186
Employees - - 0 3 3 3 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 18.7%, from 87.192 euro in the year 2023, to 102.893 euro in 2024. The Net Profit decreased by -4.088 euro, from 4.298 euro in 2023, to 186 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Novoclinique Srl

Rating financiar

Financial Rating -
NOVOCLINIQUE SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Novoclinique Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Novoclinique Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Novoclinique Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Novoclinique Srl - CUI 37831190

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 0 32.664 38.657 43.141 39.347 34.797 28.634 22.451
Current Assets - - 43.826 2.955 5.285 583 490 3.916 3.258 3.488
Inventories - - 0 2.559 5.017 0 0 0 0 0
Receivables - - 43.782 0 178 89 0 3.430 2.485 170
Cash - - 44 395 89 493 490 486 773 3.318
Shareholders Funds - - 44 -5.696 -21.126 -18.224 1.117 6.834 11.111 11.234
Social Capital - - 44 43 42 41 40 41 40 40
Debts - - 0 25.652 55.386 43.224 22.792 18.091 9.415 5.770
Income in Advance - - 43.782 23.694 21.567 18.724 15.928 13.789 11.366 8.936
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8690 - 8690"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 3.488 euro in 2024 which includes Inventories of 0 euro, Receivables of 170 euro and cash availability of 3.318 euro.
The company's Equity was valued at 11.234 euro, while total Liabilities amounted to 5.770 euro. Equity increased by 186 euro, from 11.111 euro in 2023, to 11.234 in 2024. The Debt Ratio was 22.2% in the year 2024.

Risk Reports Prices

Reviews - Novoclinique Srl

Comments - Novoclinique Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.